|
|
ABCIXIMAB
Resources
MedlinePlus Drug Information: Abciximab (Systemic): Abciximab reduces the chance that a harmful clot will form by preventing http://www.clinicaltrials.gov/ct/show/NCT00073372 Clinical Trial: Abciximab (ReoPro) in Acute Ischemic Stroke: Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled trial http://www.clinicaltrials.gov/ct/gui/show/NCT00073372 Clinical Trial: Abciximab (ReoPro) in Acute Ischemic Stroke: Placebo-controlled trial to evaluate efficacy and safety of Abciximab in http://www.fda.gov/cder/biologics/products/abcicen110597.htm Menu Page-DrugInfo Template: Abciximab Product Approval Information - Licensing Action. ... Proper name: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=12242074&dopt=abstract Safety and efficacy of abciximab combined with dalteparin in ...: Major and minor bleedings were more frequent for abciximab (24 and 48 h http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?holding=npg&cmd=Retrieve&db=PubMed&list_uids=12083481&dopt=Abstract An additional mechanism of action of abciximab: dispersal of newly ...: BACKGROUND: The ability of abciximab to prevent fibrinogen binding to http://www.guidelines.gov/summary/summary.aspx?view_id=1&doc_id=5899 Antithrombotic therapy during percutaneous coronary intervention ...: Remark: Whenever possible, abciximab should be started prior to balloon http://www.4woman.gov/News/English/517594.htm 2004.02.24 -- Taking Blood Pressure at Home Makes Sense: One drug, abciximab (brand name ReoPro), has been shown to help reduce heart http://www.oqp.med.va.gov/cpg/IHD/IHD_CPG/CONTENT/module_B/B_H_anno.htm Module B, Annotation H: The intravenous Glycoprotein IIb/IIIa inhibitor drugs, abciximab, ... But the http://www.oqp.med.va.gov/cpg/IHD/IHD_CPG/CONTENT/module_B/B_G_anno.htm Module B, Annotation G: Abciximab. Abciximab is bolused at 0.25 mg/kg, then infused at 0.125 http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=325487 Low-molecular-weight heparin and abciximab for thrombo-occlusive ...: ...disease was treated with the aid of abciximab during the intervention and with http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=64821 Debate: PCI or CABG for multivessel disease? Viewpoint: No clear ...: ...in patients receiving stents who were randomized to abciximab instead of http://ott.od.nih.gov/db/abstxt.asp?refno=954 Technology Abstracts (Text Only Version): Abciximab Pharmacodynamic Pattern Recognition. Description of Invention: http://www.guideline.gov/summary/summary.aspx?doc_id=5899&nbr=3885&ss=6&xl=999 Antithrombotic therapy during percutaneous coronary intervention ...: ...the guideline developers recommend abciximab over eptifibatide (Grade 1B). http://clinicalstudies.info.nih.gov/detail/A_2002-N-0154.html Academic resources: http://cvmed.stanford.edu/interventional/acutemi.htm Acute MI: ...setting of an acute MI. RAPPORT 5 examined the use of abciximab (ReoPro http://moon.ouhsc.edu/jgeorge/ABCIXIMAB%20c7E3%20FA1.htm ABCIXIMAB c7E3 FAB: ABCIXIMAB c7E3 FAB. NEJM 244:1888-1894. 2001. Adult. 102. 0.67. 3.57. I. NA. CLOPIDOGREL. http://moon.ouhsc.edu/jgeorge/DRUG%20NAME1.htm DRUG NAME: ABCIXIMAB c7E3 FAB. QJ MED 95:635-638. 2002. 55 YRS. M. No. Yes. 1. 3. NA. ABCIXIMAB http://www.cpb.uokhsc.edu/fda/ans/bull1100.html FDA T94-59: FDA has been receiving inquiries about the licensing of Abciximab, a monoclonal http://public.bcm.tmc.edu/medicine/kleiman.htm BCM Department of Medicine: Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: http://www.cardiology.utmb.edu/Archive/slides/Cardiac-markers/sld006.htm Benefit of Abciximab in Patients with Refractory USA in relation ...: ...www.cardiology.utmb.edu/Archive/ slides/Cardiac-markers/sld006.htm - 3k - Cached - Similar pages Penn State News http://www.psu.edu/ur/2004/dosing.html Penn State News: A computer-aided approach -- based on software-that-learns -- promises to provide http://faculty.washington.edu/momus/PB/mimrp.htm Dr. Rose's Peripheral Brain-ACUTE MI AND OTHER ACUTE CORONARY ...: Alteplase (100mg accelerated-dose) Abciximab 0.24mg/kg bolus plus 0.125mg/kg/min http://www.cs.princeton.edu/~lreyzin/IWSpring2004/info/Reopro.txt Abciximab: Should It Be Standard Care for Patients Having ...: Abciximab: Should It Be Standard Care for Patients Having Angioplasty? http://www.cs.princeton.edu/~lreyzin/IWSpring2004/info/Is_Abciximab_worth_cost.txt Is Abciximab Worth the Cost? Drug & Ther Perspect 13(5):13-16 ...: Is Abciximab Worth the Cost? Drug & Ther Perspect 13(5):13-16, 1999 Abciximab http://www.baylorhealth.edu/proceedings/13_2/13_2_gurkturner.html Pharmacology Notes: Glycoprotein IIb/IIIa receptor antagonists: a ...: All studies were double blind, randomized, and placebo controlled. ABCIXIMAB http://www.dartmouth.edu/~cardio/providereducation/STEMI_Niles.htm Management of the ST Elevation Myocardial Infarction: ...at 30 days in patients treated with either standard dose reteplase or the combination http://www.med.unc.edu/isth/SSC/04sscminutes/04plateletimmunology.html Platelet Immunology 2004 Minutes: ...sometimes acutely), 0.67% for xemilofiban, 0.67% for orbofiban, 0.4-1.3% for http://www2.umdnj.edu/rdayweb/index_home.htm RWJMS Research Day: Keynote Speaker: He developed a monoclonal antibody that inhibits platelet function and a derivative http://healthinfo.cedars-sinai.edu/healthyliving/familyhome/jan05bloodpressure.htm Drug ingredients index Search the web for more on ABCIXIMAB : Mongabay Home | Rainforests | Madagascar | Contact ] © 2006 Rhett A. Butler. |
|
Copyright Rhett A. Butler 2006 |
